Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $216.00
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price raised by Mizuho from $212.00 to $216.00 in a research note published on Thursday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. Other analysts have also issued reports about the company. Royal Bank of Canada lifted their price objective on Axsome […]
More Stories
ZoomInfo Technologies Inc. (NASDAQ:ZI) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted its holdings in ZoomInfo Technologies Inc. (NASDAQ:ZI – Free Report) by 35.4% during the 4th...
Prudential Financial Inc. Decreases Stake in SpartanNash (NASDAQ:SPTN)
Prudential Financial Inc. lessened its holdings in shares of SpartanNash (NASDAQ:SPTN – Free Report) by 31.4% in the 4th quarter,...
KLP Kapitalforvaltning AS Purchases New Position in TransMedics Group, Inc. (NASDAQ:TMDX)
KLP Kapitalforvaltning AS acquired a new position in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) in the 4th quarter, Holdings...
KLP Kapitalforvaltning AS Acquires Shares of 4,900 Triumph Financial, Inc. (NASDAQ:TFIN)
KLP Kapitalforvaltning AS acquired a new stake in Triumph Financial, Inc. (NASDAQ:TFIN – Free Report) in the 4th quarter, according...
KLP Kapitalforvaltning AS Makes New Investment in LiveRamp Holdings, Inc. (NYSE:RAMP)
KLP Kapitalforvaltning AS purchased a new position in LiveRamp Holdings, Inc. (NYSE:RAMP – Free Report) during the fourth quarter, Holdings...
Blair William & Co. IL Has $372,000 Stock Position in Haleon plc (NYSE:HLN)
Blair William & Co. IL lessened its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 3.1% during...